Alka Hasani
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Bacterial biofilms and quorum sensing 27
- Gut microbiota and health 13
-
- Antibiotic Resistance in Bacteria 43
- Co-authors
- Mohammad Ahangarzadeh Rezaee (58 shared papers)Hossein Samadi Kafil (26 shared papers)Reza Ghotaslou (18 shared papers)Akbar Hasani (25 shared papers)Mohammad Aghazadeh (16 shared papers)Mohammad Reza Nahaei (13 shared papers)Pourya Gholizadeh (11 shared papers)Fatemeh Hemmati (8 shared papers)
- Journals
- Microbial Drug Resistance (4 papers)Current Pharmaceutical Biotechnology (3 papers)Microbial Pathogenesis (3 papers)Infection and Drug Resistance (3 papers)Letters in Applied Microbiology (3 papers)
- Partner nations
- IranTürkiyeAzerbaijan
In The Last Decade
Alka Hasani
96 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Molecular Medicine 705
- Applied Microbiology and Biotechnology 146
- Endocrinology 283
- Clinical Biochemistry 147
- Infectious Diseases 278
Countries citing papers authored by Alka Hasani
This map shows the geographic impact of Alka Hasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alka Hasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alka Hasani more than expected).
Fields of papers citing papers by Alka Hasani
This network shows the impact of papers produced by Alka Hasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alka Hasani. The network helps show where Alka Hasani may publish in the future.
Co-authors
The 25 scholars most cited alongside Alka Hasani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 119 | |
| 2 | High prevalence of metallo-beta-lactamase-producing acinetobacter baumannii in a teaching hospital in Tabriz, Iran. | 2011 | 70 |
| 3 | 2013 | 59 | |
| 4 | 2020 | 58 | |
| 5 | 2020 | 56 | |
| 6 | 2012 | 55 | |
| 7 | 2017 | 50 | |
| 8 | Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran. | 2016 | 50 |
| 9 | 2011 | 49 | |
| 10 | 2016 | 43 | |
| 11 | 2016 | 43 | |
| 12 | 2016 | 42 | |
| 13 | 2020 | 37 | |
| 14 | 2017 | 37 | |
| 15 | 2011 | 37 | |
| 16 | 2020 | 35 | |
| 17 | 2017 | 33 | |
| 18 | 2018 | 31 | |
| 19 | 2011 | 29 | |
| 20 | 2024 | 28 |
About Alka Hasani
Alka Hasani is a scholar working on Molecular Biology, Molecular Medicine, Infectious Diseases, Endocrinology and Epidemiology, having authored 99 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (43 papers), Bacterial biofilms and quorum sensing (27 papers), Antimicrobial Resistance in Staphylococcus (19 papers), Gut microbiota and health (13 papers), Bacterial Identification and Susceptibility Testing (13 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Escherichia coli research studies (8 papers) and Antibiotic Use and Resistance (8 papers). The work is most often cited by research in Molecular Medicine (705 citations), Applied Microbiology and Biotechnology (146 citations), Endocrinology (283 citations), Clinical Biochemistry (147 citations) and Infectious Diseases (278 citations). Alka Hasani has collaborated with scholars based in Iran, Türkiye and Azerbaijan. Frequent co-authors include Mohammad Ahangarzadeh Rezaee, Hossein Samadi Kafil, Reza Ghotaslou, Akbar Hasani, Mohammad Aghazadeh, Mohammad Reza Nahaei, Pourya Gholizadeh, Fatemeh Hemmati, Hamid Reza Goli and Yaeghob Sharifi. Their work appears in journals such as Microbial Drug Resistance, Current Pharmaceutical Biotechnology, Microbial Pathogenesis, Infection and Drug Resistance and Letters in Applied Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.